[1]胡 骏,薛礼浚,邵 蓉.美国专业药房研究及其对我国DTP药房的启示[J].卫生经济研究,2018,(11):31-34.
　HU Jun,XUE Li-jun,SHAO Rong.Research on American Professional Pharmacy and Its Enlightenment to China's DTP Pharmacy[J].Journal Press of Health Economics Research,2018,(11):31-34.
点击复制

美国专业药房研究及其对我国DTP药房的启示
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
期数:
2018年11期
页码:
31-34
栏目:
他山之石
出版日期:
2018-10-29

文章信息/Info

Title:
Research on American Professional Pharmacy and Its Enlightenment to China's DTP Pharmacy
作者:
胡 骏1; 薛礼浚1; 邵 蓉1
1.中国药科大学，江苏 南京 200233
Author(s):
HU Jun; XUE Li-jun; SHAO Rong
China Pharmaceutical University，Nanjing Jiangsu 200232，China
关键词:
专业药房; DTP药房; 药事服务
Keywords:
professional pharmacy; DTP pharmacy; pharmaceutical service
分类号:
R19
文献标志码:
A
摘要:
研究美国专业药房的发展历程以及关键节点的必要条件，对比我国DTP药房的现状、相关政策、市场环境，为我国DTP药房的定位与发展提供参考。目前我国DTP药房的发展还处于初级阶段，医药分开、“两票制”等政策以及商业保险的快速发展，为我国DTP药房的发展注入了强劲动力。综合美国专业药房经验来看，我国DTP药房应着重提升药事服务能力，从而在医疗市场中开拓更广阔的空间。
Abstract:
This paper studied the development history of American professional pharmacies and the necessary conditions of key nodes，compared the status quo，relevant policies and market environment of DTP pharmacies in China，and provided reference for the positioning and development of DTP pharmacies in China. At present，the development of DTP pharmacies in China is still at an early stage. The separation of medicines，the "two-vote system" and the rapid development of commercial insurance have injected strong momentum into the development of DTP pharmacies in China. Based on the experience of American professional pharmacies，China's DTP pharmacies should focus on improving the pharmacy service capabilities，thus opening up a broader space in the medical market.

参考文献/References:

[1] Stein J, Mann J. Specialty pharmacy services for patients receiving oral medications for solid tumors[J]. American Journal of Health-System Pharmacy, 2016, 73(11): 775-796.
[2] Kober S. The evolution of specialty pharmacy[J]. Biotechnology Healthcare, 2008, 5(2):50.
[3] Orange J, Kirkham H, Ayer G, et al. Improved Clinical Outcomes for Patients Receiving Immunoglobulin Therapy Through Specialty Pharmacy or Home Infusion Services[C].ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC, 2015, 115(5): A18.
[4] US Food and Drug Administration. FDA Basics webinar: a brief overview of Risk Evaluation and Mitigation Strategies (REMS),2012[Z]. 2017.
[5] 干荣富. 美国医院药房和社会药房运作模式给我们的启示[J]. 中国医药工业杂志, 2008, 39(1):65-68.
[6] Dong X, Fetterolf D. Specialty pharmacy: an emerging area of interest for medical management[J]. Disease Management Dm, 2005, 8(2):73.
[7] Miller, Steve B, Hoffman, Tracy A, Houts, Jonah C, et al. The Rise of Specialty Pharmacy Costs: Issues for Providers, Payers, and Patients[J]. Disease Management and Health Outcomes, 2007, 15(2):83-89.
[8] 彭浩然, 郑倩昀, 呙玉红. 中国社会医疗保险扩张会促进商业健康保险发展吗?[J]. 金融研究, 2017(5):97-110.
[9] 羊晨, 黄康妹, 张宇翔,等. 药品流通“两票制”效果及对策分析——基于交易成本理论[J]. 卫生经济研究, 2018(2):12-14.

更新日期/Last Update: 2018-10-29